The submission has been desk rejected. The chances of acceptance for non-immune-related topics are low.

(0) 讚！ | Javen.Wu

I am not immune, so I decided to give it a try to see if I will be rejected by the table. I see that there are also a small number of non-immune people in their article.

(0) 讚！ | lz

Hey guys, does this magazine only accept articles on immunology?

(0) 讚！ | Javen-Dr.Wu

Boss, could you please provide the complete timeline for me to review? Thank you.

(0) 讚！ | King Julian

Review Speed: 1.0 | Submission Acceptance Rate: 25.0 
Emphasized Research Area: Immunology 
Experience Sharing: Articles on immunology are recommended

(0) 讚！ | 破戒曼珍

What magazine is G & D?

(0) 讚！ | 平原英豪

Hello, may I ask how long it took for you to reply?

(0) 讚！ | 梦晨小公主

It's really not easy

(0) 讚！ | 香雪大叔

Hello, may I ask how long is the preliminary review process expected to take?

(0) 讚！ | 无相秀菊

It's not easy

(0) 讚！ | 香雪大叔

Not very positive, it's tragic

(0) 讚！ | 慧俊小仙女

JEM, EMBO J, JCI, G&D are all my dream journals, and I want them all!

(0) 讚！ | 辉夜一莹

It's been 12 days since submission, and the status is still "Initial Manuscript Assessment Started." Should I send an email to inquire about it?

(0) 讚！ | 长安元绿

How about it? Have the opinions come back? How many reviewers? Are the opinions positive?

(0) 讚！ | 长安元绿

Review speed: 1.0 | Submission acceptance rate: 25.0 Emphasis on research direction: Immunology Experience sharing: Submitted in January, reviewed by two reviewers, both opinions were relatively positive. Spent 3 months doing additional experiments, then accepted in February, and officially online a month and a half later. Original Western Blot data needs to be provided

(0) 讚！ | 语萍酱大魔王

Sure

(0) 讚！ | 慧俊小仙女

Submission acceptance rate: 50.0
Preferred research direction: Immunology
Sharing of immunological experiences: This is the time to wait for revision comments. Under External Review. 2022-02-22 Initial Manuscript Assessment Started. Initial QC Complete. 2022-02-10 Initial QC Started. 2022-02-09 Author Approved Converted Files. 2022-02-09 Preliminary Manuscript Data Submitted

(0) 讚！ | 慧俊小仙女

Will I receive an email notification for the review meeting?

(0) 讚！ | 静心经义

ORCID is the Researcher and Contributor ID, an open nonprofit organization. The ORCID ID is a unique and persistent academic identity for contributors, allowing authors to be distinguished from other researchers and to document all related research activities

(0) 讚！ | 维尔娜菲茨杰拉德

What is ORCID ID? How to register?

(0) 讚！ | Oswald Edie

Review Speed: 1.0
Focus of Study: Immunology
Experience Sharing: The reviewers are all immunology experts, very friendly, and ask questions quite professionally. The manuscript underwent major revisions on 3 figures, with the following timeline:
Preliminary Manuscript Data Submitted 2021-01-02 22:40:02
Under External Review 2021-01-14 17:08:05
Decision Sent to Author 2021-02-16 16:07:39
Revision Received 2021-05-05 22:26:29
Decision Sent to Author 2021-06-08 16:45:18
Manuscript Sent to Production 2021-06-17 16:08:32

(0) 讚！ | 桃花欣嘉

May I ask how many reviewers are there? Thank you very much

(0) 讚！ | 斯羽酱吖

Congratulations! How many reviewers were there at that time?

(0) 讚！ | 斯羽酱吖

Hello, may I ask about your experience in submitting articles to JEM? Would you be willing to discuss it privately?

(0) 讚！ | Nigel Frederick

Review speed: 1.0 | Submission acceptance rate: 25.0
Sharing of experience: First review takes one month, just for your reference

(0) 讚！ | 筑阳婵娟